Biotech firm ToolGen opens research center

BY admin

ToolGen Inc., a South Korean biotech company, opened a research and development (R&D) center to step up its development of gene editing technology, company officials said Friday.

The center, located in the city of Cheongju, is equipped with cutting-edge facilities to study seed development, including a walk-in chamber and a speed breeding chamber.

ToolGen is South Korea’s only company that owns a patent for the CRISPR-Cas9 foundational technology.

Developed in 2012, CRISPR-Cas9 is a gene editing technology that allows the highly specific and rapid modification of DNA in a genome, following earlier gene editing techniques of Zinc Finger (ZFN) and Transcription Activator-Like Effector Nucleases.

“The R&D center will become an outpost for the company’s global business, including an expansion of business, technology transfer and sales,” ToolGen CEO Lee Byong-hwa said.

Source: Yonhap News Agency

Related Posts

General

Seoul shares down late Wed. morning ahead of U.S. inflation data

South Korean stocks traded lower late Wednesday morning ahead of key U.S. inflation data that would serve as a precursor to the Fed's rate-setting decision next week. The benchmark Korea Composite

General

Volunteer fighter gets suspended prison term for illegal entry into Ukraine

A South Korean volunteer fighter indicted for entering Ukraine in 2022 to fight against Russia's invasion in violation of the passport law was given a suspended prison sentence by a court Thursday.Th

General

One missing, over 40 evacuated due to heavy rains

An elderly woman was reported missing and over 40 people were evacuated in heavy rains that swept across the country, officials said Wednesday.The downpours lashed many parts of the country, includin

Copyright @2024 - Korea News Gazette | WordPress Theme: Xews Lite